Quark Biosciences, Inc. combines biotechnology with optoelectronic semiconductor technology to develop a dual-function dqPCR gene detection platform instrument, PanelChip® multiplex gene detection chips, and DigiChipTM high-sensitivity quantitative gene detection chips. They have introduced a range of innovative and advanced products for precision cancer medicine and reproductive medicine applications, providing customized testing solutions.

Quark is located in the Hsinchu Biomedical Science Park and is continuously developing new products, pursuing international certifications, and actively collaborating with biotechnology companies, pharmaceutical companies, and medical institutions both domestically and internationally. They currently hold approximately 50 international patents, and their products and applications are rapidly entering the Asia-Pacific and European-American markets.